The continuing share dilution is probably necessary to stay alive, and we all want that. But we have to acknowledge, the pairing with EAGLE PHARMACEUTICAL just placed us at (more or less) at 132 Million shares. For only a $10 market cap, we nees a $13.2 PPS.
I think it's very possible, BUT.... thats a hell of a threshold to reach for a company who is comprised of just a couple of Manhattan offices. Incredible actually.
Only thing we have out there is our Intellectual Properties, a couple of work stations and janitorial supplies.
Our success to date is incredible. For the future, chancy.
Hoping for the best. Good luck to you and all.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM